Back to search
FDAFDA · Food and drugs·Recall number D-832-2013

Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01.

Published August 14, 2013 · Recall initiated: May 20, 2013

Summary

FDA records drug Class I recall D-832-2013, published August 14, 2013 and initiated May 20, 2013. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 1,635 vials; Lot: Lot #: CL0996, Exp 12/13; and CJ4948, Exp 05/13. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Found during examination of retention samples.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Incorporated
Distributor
Nationwide
Lot
Lot #: CL0996, Exp 12/13; and CJ4948, Exp 05/13
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540; Manufactured by: EBEWE Pharma Ges.m.b.H. Nfg.KG, A-4866 Unterach, AUSTRIA, NDC 66758-041-01. recalled?

Yes. FDA published recall D-832-2013 on August 14, 2013. Reported hazard: Presence of Particulate Matter: Found during examination of retention samples.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release